Topic: Pfizer Inc.

Pfizer gets EU approval for cholesterol blockbuster Lipitor in children with high blood fatsThe European Union has approved a new chewable form of cholesterol blockbuster Lipitor for children 10 and up with high levels of bad cholesterol and triglycerides, a type of ...
Pfizer gets FDA warning letter for failing to report drug side-effect reportsFederal regulators have warned Pfizer for failing to promptly report complaints with its drugs that may have involved serious injury. Pfizer repeatedly failed to submit product complaints to the Food and ...

Lipitor generic reaches Canada, Pfizer vows fight

TORONTO/NEW YORK (Reuters) - Apotex Inc said on Wednesday it would immediately launch in Canada a copycat form of Pfizer Inc's blockbuster Lipitor cholesterol fighter, and Pfizer vowed to fight back with its own Lipitor generic. Apotex said it is rolling out ...

Benefit of Merck heart drug remains after stopping

ORLANDO, Florida (Reuters) - High doses of an experimental heart medicine being developed by Merck & Co MRK.N continued to show beneficial effects on both good HDL and bad LDL cholesterol levels eight weeks after patients stopped taking the drug, in a ...
U.S. regulators have refused to accept drugmaker Merck & Co.'s application for a new, combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug. Merck disclosed the rare move by the Food and Drug Administration in a regulatory filing Monday. ...
Merck: FDA won't accept its application for combo cholesterol pill including Pfizer's LipitorU.S. regulators have refused to accept drugmaker Merck & Co.'s application for a new, combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug. Merck disclosed the rare ...
eXEC: Pfizer retooling business, pushing emerging market sales ahead of Lipitor patent lossPfizer Inc. is dramatically stepping up sales efforts in emerging markets, overhauling U.S. business operations and slashing more costs ahead of the 2011 patent loss for cholesterol blockbuster Lipitor, its ...
After controversy over Lipitor endorser, Pfizer starts new ads with heart attack survivorTelevision ads for the world's top-selling drug, cholesterol fighter Lipitor, are back, six months after Pfizer Inc. pulled them amid charges its use of a celebrity doctor endorser who's never ...